SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (74)2/11/2000 11:34:00 PM
From: margie  Read Replies (2) of 1833
 
<Could you please publicize/hype, associated with Cadus, all over the net and all day on Monday? You can go back and clarify at 4:01 p.m., Eastern.No.>

<g>
I don't own Cadus. It does look like it could use some publicity. Not too many "cheap" biotech stocks around these days.

My father has CHF, among other things, and takes furosemide, among other things.
I don't know if I understand that abstract. Is that what it means? If so, it sounds promising.

Kadus' adenosine receptor BG9719 caused less sodium loss than furosemide, a plus?
Furosemide decreased the GFR- a negative.
The GFR was unaffected by BG9719-a plus
RPF increased with BG9719 but more so with furosemide
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext